Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Marcin Kosmalski, Rafał Frankowski, Sylwia Ziółkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1852-1852
Open Access | Times Cited: 21

Showing 21 citing articles:

Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action
Zobair M. Younossi, Linda Henry
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 9-19
Open Access | Times Cited: 17
Exposure to environmental toxicants is associated with gut microbiome dysbiosis, insulin resistance and obesity
Partho Sen, Yong Fan, Jennifer J. Schlezinger, et al.
Environment International (2024) Vol. 186, pp. 108569-108569
Open Access | Times Cited: 16
A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
Gabriele Castelnuovo, Nuria Pérez-Díaz-del-Campo, Chiara Rosso, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2027-2027
Open Access | Times Cited: 7
Efficacy of fish oil supplementation on metabolic dysfunction-associated steatotic liver disease: a meta-analysis
Li Zhou, Dongmei Sun, Houqiao Bai
Frontiers in Nutrition (2025) Vol. 12
Open Access
Artificial Intelligence‐Based Diets: A Role in the Nutritional Treatment of Metabolic Dysfunction‐Associated Steatotic Liver Disease?
Tuğçe ÖZLÜ, Emre Batuhan Kenger, Yusuf Yılmaz
Journal of Human Nutrition and Dietetics (2025) Vol. 38, Iss. 2
Closed Access
The Influence of Diet and Its Components on the Development and Prevention of Hepatocellular Carcinoma (HCC)
Barbara Janota, Barbara Szymanek
Cancers (2024) Vol. 16, Iss. 5, pp. 1030-1030
Open Access | Times Cited: 4
Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review
Kasey Moss, Victor Gitman, María Inés Pinto-Sánchez, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e079750-e079750
Open Access | Times Cited: 3
Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds
Marcin Kosmalski, Rafał Frankowski, Kacper Deska, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2838-2838
Open Access | Times Cited: 7
Prolonged Cold Exposure Negatively Impacts Atlantic Salmon (Salmo salar) Liver Metabolism and Function
Isis Rojas, Albert Caballero‐Solares, Émile Vadboncoeur, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 494-494
Open Access | Times Cited: 2
Single-Nucleotide Polymorphisms in Base-Excision Repair-Related Genes Involved in the Risk of an Occurrence of Non-Alcoholic Fatty Liver Disease
Sylwia Ziółkowska, Marcin Kosmalski, Łukasz Kołodziej, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11307-11307
Open Access | Times Cited: 4
Saponins of Tomato Extract Improve Non-Alcoholic Fatty Liver Disease by Regulating Oxidative Stress and Lipid Homeostasis
Ziming Yang, Li Zhang, Jinlei Liu, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1848-1848
Open Access | Times Cited: 4
Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: Therapeutic insights and strategies
Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Govind K Pradeep, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104064-104064
Closed Access | Times Cited: 1
The Association between Personality Factors and Metabolic Parameters among Patients with Non-Alcoholic-Fatty Liver Disease and Type 2 Diabetes Mellitus—A Cross-Sectional Study
Marcin Kosmalski, Rafał Frankowski, Monika Różycka-Kosmalska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4468-4468
Open Access | Times Cited: 3
Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries
Margherita Sisto, Sabrina Lisi
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5699-5699
Open Access | Times Cited: 3
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD).
Atie Moghtadaie, Hamidreza Mahboobi, Somayeh Fatemizadeh, et al.
PubMed (2023) Vol. 22, pp. 946-974
Closed Access | Times Cited: 3
Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
Yuan Yao, Yunfeng Shen
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
The Development of Nonalcoholic Fatty Liver Disease and Metabolic Syndromes in Diet-Induced Rodent Models
Bayan Abdulhafid Aljahdali, Adnan S. Bajaber, Doha M. Al-Nouri, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1336-1336
Open Access | Times Cited: 2
Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries
Margherita Sisto, Sabrina Lisi
(2023)
Open Access | Times Cited: 2
Clinical Guidelines on Nonalcoholic Fatty Liver Disease—Reply
Peggy B. Leung, Andrew M. Davis, Sonal Kumar
JAMA (2024) Vol. 331, Iss. 12, pp. 1063-1063
Closed Access
Synergistic impact of Composite Dietary Antioxidant Index and physical activity on fatty liver disease
Linxiao Gao, H. Fang, Zhibo Zhao, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Exploring the Hepatic Benefits of Skipjack Tuna (Katsuwonus pelamis) Dark Muscle Hydrolysate in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease
Fangfang Huang, Qingfei Dai, Kewei Zheng, et al.
Food Bioscience (2024), pp. 105786-105786
Closed Access
Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
Jing‐Hua Wang
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1140-1140
Open Access
Page 1

Scroll to top